Dongo , V. . (2023). Budgetary impact of emicizumab versus activated prothrombin complex concentrate (aPCC) for the prophylactic treatment of hemophilia A with inhibitors. Revista Del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo, 16(3). https://doi.org/10.35434/rcmhnaaa.2023.163.1977